Variant report
Variant | nsv538273 |
---|---|
Chromosome Location | chr6:64870667-64900058 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:64898967..64901155-chr6:64903465..64905780,2 | K562 | blood: | |
2 | chr6:64825086..64826621-chr6:64878332..64879949,2 | K562 | blood: | |
3 | chr20:46132660..46133356-chr6:64886601..64887388,2 | MCF-7 | breast: | |
4 | chr12:81340169..81340734-chr6:64895212..64895734,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117112928 | chr6:64870731-64870732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532007883 | chr6:64870828-64870829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191588168 | chr6:64870887-64870888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370237282 | chr6:64870921-64870922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374949650 | chr6:64870955-64870956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571925596 | chr6:64870966-64870967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532570892 | chr6:64870995-64870996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183492048 | chr6:64871028-64871029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185631440 | chr6:64871050-64871051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74866409 | chr6:64871063-64871064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554999643 | chr6:64871099-64871100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569980028 | chr6:64871128-64871129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190091523 | chr6:64871135-64871136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528246253 | chr6:64871137-64871138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138989719 | chr6:64871164-64871165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182294051 | chr6:64871217-64871218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577717219 | chr6:64871275-64871276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs540827521 | chr6:64871289-64871290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74610636 | chr6:64871298-64871299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574188751 | chr6:64871314-64871315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541551924 | chr6:64871345-64871346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs74450536 | chr6:64871396-64871397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565668947 | chr6:64871410-64871411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149880124 | chr6:64871416-64871417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547064932 | chr6:64871490-64871491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186607210 | chr6:64871507-64871508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115155285 | chr6:64871531-64871532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565396182 | chr6:64871542-64871543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532853207 | chr6:64871551-64871552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11967277 | chr6:64871566-64871567 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs530845099 | chr6:64871594-64871595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577611358 | chr6:64879604-64879605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77836732 | chr6:64879607-64879608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553404237 | chr6:64879623-64879624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74940307 | chr6:64879631-64879632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75829614 | chr6:64879642-64879643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549100592 | chr6:64879656-64879657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200806713 | chr6:64879676-64879677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143506115 | chr6:64879683-64879684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530948679 | chr6:64879724-64879725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545788897 | chr6:64879788-64879789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373981013 | chr6:64879815-64879816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142699770 | chr6:64879816-64879817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528115261 | chr6:64879828-64879829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528353028 | chr6:64879848-64879849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546455941 | chr6:64879868-64879869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116064153 | chr6:64879877-64879878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529038713 | chr6:64879878-64879879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571226474 | chr6:64879884-64879885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538408494 | chr6:64879919-64879920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:64869600-64871400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr6:64869800-64871600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr6:64879600-64880600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr6:64879800-64880600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr6:64880200-64881000 | Enhancers | Fetal Lung | lung |
6 | chr6:64880600-64885200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr6:64880600-64885200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr6:64885200-64885800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr6:64885200-64886000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr6:64895800-64896400 | Enhancers | Fetal Lung | lung |
11 | chr6:64896400-64897000 | Flanking Active TSS | Fetal Lung | lung |
12 | chr6:64897000-64897800 | Enhancers | Fetal Lung | lung |